WallStSmart

AvalonBay Communities Inc (AVB)vsJanus Living, Inc. (JAN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

AvalonBay Communities Inc generates 367% more annual revenue ($3.06B vs $655.41M). AVB leads profitability with a 37.3% profit margin vs -0.0%. AVB earns a higher WallStSmart Score of 59/100 (C).

AVB

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 7.5Value: 4.7Quality: 4.0
Piotroski: 3/9Altman Z: 1.01

JAN

Avoid

32

out of 100

Grade: F

Growth: 8.0Profit: 3.0Value: 5.0Quality: 5.3
Piotroski: 4/9Altman Z: 1.64
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AVBUndervalued (+10.9%)

Margin of Safety

+10.9%

Fair Value

$201.79

Current Price

$189.72

$12.07 discount

UndervaluedFair: $201.79Overvalued

Intrinsic value data unavailable for JAN.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AVB4 strengths · Avg: 8.5/10
Profit MarginProfitability
37.3%10/10

Keeps 37 of every $100 in revenue as profit

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
29.3%8/10

Strong operational efficiency at 29.3%

EPS GrowthGrowth
40.3%8/10

Earnings expanding 40.3% YoY

JAN2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
34.5%10/10

Revenue surging 34.5% year-over-year

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

Areas to Watch

AVB4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
2.5%4/10

2.5% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
6.972/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.012/10

Distress zone — elevated risk

JAN4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Altman Z-ScoreHealth
1.644/10

Distress zone — elevated risk

Operating MarginProfitability
0.5%3/10

Operating margin of 0.5%

Return on EquityProfitability
-0.1%2/10

ROE of -0.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : AVB

The strongest argument for AVB centers on Profit Margin, Price/Book, Operating Margin. Profitability is solid with margins at 37.3% and operating margin at 29.3%.

Bull Case : JAN

The strongest argument for JAN centers on Revenue Growth, Price/Book. Revenue growth of 34.5% demonstrates continued momentum.

Bear Case : AVB

The primary concerns for AVB are Revenue Growth, Piotroski F-Score, PEG Ratio.

Bear Case : JAN

The primary concerns for JAN are EPS Growth, Altman Z-Score, Operating Margin.

Key Dynamics to Monitor

AVB profiles as a value stock while JAN is a hypergrowth play — different risk/reward profiles.

JAN is growing revenue faster at 34.5% — sustainability is the question.

AVB generates stronger free cash flow (359M), providing more financial flexibility.

Monitor REIT - RESIDENTIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AVB scores higher overall (59/100 vs 32/100), backed by strong 37.3% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

AvalonBay Communities Inc

REAL ESTATE · REIT - RESIDENTIAL · USA

AvalonBay Communities, Inc. is a publicly traded real estate investment trust that invests in apartments.

Janus Living, Inc.

REAL ESTATE · REIT - RESIDENTIAL · USA

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for pain management. The company is headquartered in Las Vegas, Nevada.

Want to dig deeper into these stocks?